go to contents

ProFem GmbH

Back to list

Facts

Founded
2012
Staff
2
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Profile

Based on a highly innovative therapeutic concept ProFem develops new medicines for gynecological diseases which are characterized by a hitherto unmet medical need and high market potential. ProFem’s activities are currently focused on infectious diseases of the female lower genitourinary tract associated with the growth of biofilms.

R&D:About 150 million women worldwide are suffering constantly from recurrent vulvovaginal Candidosis (RVVC). This medical condition deteriorates the quality of life of infected women substantially, often for years, and currently cannot be treated successfully.

Similar companies in RDM biotech/pharma

QUANTRO Therapeutics GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Myllia Biotechnology GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
bioinformatics
Details

APEPTICO Forschung und Entwicklung GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Borealis Agrolinz Melamine GmbH

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
industrial processing
Details

Contact

Riglergasse 4
1180 Wien
Vienna

Contact: Marion Noe-Letsching (PhD, MD, CEO)
Email: marion.noe@profem.at
Website